Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

What will the ‘creatinine kinase’ be in 2016?

What will the ‘creatinine kinase’ be in 2016? Letters to the Editor / European Journal of Cardio-thoracic Surgery 31 (2007) 331—333 333 (creatinine kinase) compared with the correct term References (creatine kinase). If this trend continues, using mathema- tical modelling (y =85.1x  103.5, correlation: R = 0.9397, [1] Ates M. When should we replace the ascending aorta in Marfan syndrome? 3.6113 2 Eur J Cardiothorac Surg 2007;31:332. or y = 2.1816x , correlation: R = 0.9821), we estimate [2] Jault F, Rama A, Lievre L, Bonnet N, Leprince P, Pavie A, Gandjbakhch I. that in the next decade there will be just under 350 incorrect Chronic dissection of the ascending aorta: surgical results during a 20-year entries appearing in Medline. We are hoping that letters period. Eur J Cardiothorac Surg 2006;29:1041—5. such as this one will help reduce this number. [3] Jault F, Nataf P, Rama A, Fontanel M, Vaissier E, Pavie A, Bors V, Cabrol C, Gandjbakhch I. Chronic disease of the ascending aorta. J Thorac Cardio- vasc Surg 1994;108:747—54. [4] Rozendaal L, Groenink M, Naeff M, Hennekam R, Hart A, Van Der Wall E, Acknowledgement Mulder B. Marfan syndrome in children and adolescents: an adjusted nomogram for screening aortic root dilatation. Heart 1998;79:69—72. [5] Milewicz D, Dietz H, Miller C. Treatment of aortic disease in patients with We are grateful to S. Tsiakkouris, of the Computer marfan syndrome. Circulation 2005;111:150—7. Laboratory, University of Cambridge, UK, for his valuable assistance with mathematical modelling. * Corresponding author. Tel.: +33 1 42 16 56 43; fax: +33 1 42 16 56 39. E-mail address: frederique.jault@psl.ap-hop-paris.fr. Reference doi:10.1016/j.ejcts.2006.11.005 [1] Florath I, Albert A, Hassanein W, Arnrich B, Rosendahl U, Ennker IC, Ennker J. Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters. Eur J Cardiothorac Surg 2006;30(5):716—21 [PMID: 16965919]. Letter to the Editor * Corresponding author. Address: 3 Ventress Farm Court, Cambridge CB1 8HD, UK. Tel.: +44 7739745476; fax: +44 117 9596235. E-mail address: vassiliou@doctors.org.uk. a b c Antonis Ioannides , Adel Helmy , Ioannis Dimitropoulos , d* doi:10.1016/j.ejcts.2006.11.020 Vassilis Vassiliou Bart’s and Royal London NHS Trust, London EC1A 7BE, UK Academic Department of Neurosurgery, Addenbrooke’s Hospital, Cambridge CB2 2QQ, UK Department of Medicine, Frenchay Hospital, Bristol BS16 1JE, UK Reply to the Letter to the Editor University of Cambridge and Addenbrooke’s Hospital, Cambridge CB2 2QQ, UK Reply to Ioannides et al. Received 17 October 2006; accepted 16 November 2006; Available online 15 December 2006 Ines Florath , Alexander Albert Keywords: CK; Creatinine kinase; Creatine kinase; Myocardial damage Heart Institute Lahr/Baden, Hohbergweg 2, 77933 Lahr, Germany Reading the article by Florath and colleagues [1], we are Received 14 November 2006; accepted 16 November 2006; Available online 15 December 2006 both surprised and concerned with the use of the term ‘creatinine kinase’ as a measure of myocardial damage. We Keywords: Aortic valve replacement; Risk factors; CK; Creatine kinase; are surprised as such a term does not exist and concerned Creatinine kinase that we see this published in a specialist journal. We are certain that the authors wished to refer to creatine kinase, We apologize for misnaming the enzyme creatine kinase often abbreviated as CK, an enzyme that catalyzes the and thank Ioannides and colleagues [1] for calling the reversible phosphorylation of creatine to phosphorylcrea- attention to this point. tine. The conversion of creatine to creatinine requires no enzymatic input and no enzyme called ‘creatinine kinase’ exists. Reference We are concerned that this trend of incorrect terminology is rapidly increasing. A Medline search performed on October [1] Ioannides A, Helmy A, Dimitropoulos MA, Vassiliou V. What will the 14th, 2006 for the incorrect term ‘creatinine kinase’ ‘creatinine kinase’ be in 2016? Eur J Cardiothorac Surg 2007;31:334. revealed 437 entries. Organizing these entries according to which decade they were published, we could see that from * Corresponding author. 1966—1976 there were only 2 incorrect entries, from 1976— E-mail addresses: ines.florath@heart-lahr.com (I. Florath). 1986 there were 27, from 1986—1996 there were 170 and alexander.albert@heart-lahr.com (A. Albert). from 1996—2006 (rather worryingly) there were 238. This doi:10.1016/j.ejcts.2006.11.021 represents a disproportionate increase of the incorrect term http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cardio-Thoracic Surgery Oxford University Press

What will the ‘creatinine kinase’ be in 2016?

Download PDF
1 page

Loading next page...
 
/lp/oxford-university-press/what-will-the-creatinine-kinase-be-in-2016-G8CQz10G0B

References (7)

Publisher
Oxford University Press
Copyright
© 2007 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
Subject
Letters to the Editor
ISSN
1010-7940
eISSN
1873-734X
DOI
10.1016/j.ejcts.2006.11.020
pmid
17174558
Publisher site
See Article on Publisher Site

Abstract

Letters to the Editor / European Journal of Cardio-thoracic Surgery 31 (2007) 331—333 333 (creatinine kinase) compared with the correct term References (creatine kinase). If this trend continues, using mathema- tical modelling (y =85.1x  103.5, correlation: R = 0.9397, [1] Ates M. When should we replace the ascending aorta in Marfan syndrome? 3.6113 2 Eur J Cardiothorac Surg 2007;31:332. or y = 2.1816x , correlation: R = 0.9821), we estimate [2] Jault F, Rama A, Lievre L, Bonnet N, Leprince P, Pavie A, Gandjbakhch I. that in the next decade there will be just under 350 incorrect Chronic dissection of the ascending aorta: surgical results during a 20-year entries appearing in Medline. We are hoping that letters period. Eur J Cardiothorac Surg 2006;29:1041—5. such as this one will help reduce this number. [3] Jault F, Nataf P, Rama A, Fontanel M, Vaissier E, Pavie A, Bors V, Cabrol C, Gandjbakhch I. Chronic disease of the ascending aorta. J Thorac Cardio- vasc Surg 1994;108:747—54. [4] Rozendaal L, Groenink M, Naeff M, Hennekam R, Hart A, Van Der Wall E, Acknowledgement Mulder B. Marfan syndrome in children and adolescents: an adjusted nomogram for screening aortic root dilatation. Heart 1998;79:69—72. [5] Milewicz D, Dietz H, Miller C. Treatment of aortic disease in patients with We are grateful to S. Tsiakkouris, of the Computer marfan syndrome. Circulation 2005;111:150—7. Laboratory, University of Cambridge, UK, for his valuable assistance with mathematical modelling. * Corresponding author. Tel.: +33 1 42 16 56 43; fax: +33 1 42 16 56 39. E-mail address: frederique.jault@psl.ap-hop-paris.fr. Reference doi:10.1016/j.ejcts.2006.11.005 [1] Florath I, Albert A, Hassanein W, Arnrich B, Rosendahl U, Ennker IC, Ennker J. Current determinants of 30-day and 3-month mortality in over 2000 aortic valve replacements: impact of routine laboratory parameters. Eur J Cardiothorac Surg 2006;30(5):716—21 [PMID: 16965919]. Letter to the Editor * Corresponding author. Address: 3 Ventress Farm Court, Cambridge CB1 8HD, UK. Tel.: +44 7739745476; fax: +44 117 9596235. E-mail address: vassiliou@doctors.org.uk. a b c Antonis Ioannides , Adel Helmy , Ioannis Dimitropoulos , d* doi:10.1016/j.ejcts.2006.11.020 Vassilis Vassiliou Bart’s and Royal London NHS Trust, London EC1A 7BE, UK Academic Department of Neurosurgery, Addenbrooke’s Hospital, Cambridge CB2 2QQ, UK Department of Medicine, Frenchay Hospital, Bristol BS16 1JE, UK Reply to the Letter to the Editor University of Cambridge and Addenbrooke’s Hospital, Cambridge CB2 2QQ, UK Reply to Ioannides et al. Received 17 October 2006; accepted 16 November 2006; Available online 15 December 2006 Ines Florath , Alexander Albert Keywords: CK; Creatinine kinase; Creatine kinase; Myocardial damage Heart Institute Lahr/Baden, Hohbergweg 2, 77933 Lahr, Germany Reading the article by Florath and colleagues [1], we are Received 14 November 2006; accepted 16 November 2006; Available online 15 December 2006 both surprised and concerned with the use of the term ‘creatinine kinase’ as a measure of myocardial damage. We Keywords: Aortic valve replacement; Risk factors; CK; Creatine kinase; are surprised as such a term does not exist and concerned Creatinine kinase that we see this published in a specialist journal. We are certain that the authors wished to refer to creatine kinase, We apologize for misnaming the enzyme creatine kinase often abbreviated as CK, an enzyme that catalyzes the and thank Ioannides and colleagues [1] for calling the reversible phosphorylation of creatine to phosphorylcrea- attention to this point. tine. The conversion of creatine to creatinine requires no enzymatic input and no enzyme called ‘creatinine kinase’ exists. Reference We are concerned that this trend of incorrect terminology is rapidly increasing. A Medline search performed on October [1] Ioannides A, Helmy A, Dimitropoulos MA, Vassiliou V. What will the 14th, 2006 for the incorrect term ‘creatinine kinase’ ‘creatinine kinase’ be in 2016? Eur J Cardiothorac Surg 2007;31:334. revealed 437 entries. Organizing these entries according to which decade they were published, we could see that from * Corresponding author. 1966—1976 there were only 2 incorrect entries, from 1976— E-mail addresses: ines.florath@heart-lahr.com (I. Florath). 1986 there were 27, from 1986—1996 there were 170 and alexander.albert@heart-lahr.com (A. Albert). from 1996—2006 (rather worryingly) there were 238. This doi:10.1016/j.ejcts.2006.11.021 represents a disproportionate increase of the incorrect term

Journal

European Journal of Cardio-Thoracic Surgery – Oxford University Press

Published: Feb 1, 2007

Keywords: Keywords CK Creatinine kinase Creatine kinase Myocardial damage

There are no references for this article.